Making Medicines in America: How Congress Can Help America’s AI, Biopharma, and Manufacturing Industries Make It Happen
Information Technology & Innovation Foundation
The United States faces a crisis in its pharmaceutical supply chain. Over 70 percent of active pharmaceutical ingredients are made overseas, with China dominating key supply chains and AI-driven manufacturing accelerating its lead. The consequences for Americans include record drug shortages, heightened national security risks, and soaring costs that threaten American patients and U.S. economic stability.
It’s time to take action. America has the technology, talent, and urgency to lead in next-generation drug manufacturing, and must make a strategic pivot toward pharmaceutical independence through economic revitalization and modernizing regulation to unshackle AI-driven innovation.